Literature DB >> 8393094

Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.

H Reichmann1, S Flörke, G Hebenstreit, H Schrubar, P Riederer.   

Abstract

Biochemical and mitochondrial DNA analyses were performed in post-mortem brain tissue from seven patients with dementia of Alzheimer's type and age- and sex-matched controls. We analysed all complexes of the respiratory chain in four regions, i.e. temporal, parietal, entorhinal cortex and hippocampus. Although enzymes representing complex II, III and IV were reduced in activity, succinate cytochrome c reductase was significantly reduced only in the parietal and temporal cortex. However, Southern blot analyses with two restriction enzymes excluded any deletions larger than 500 bp in parietal and entorhinal cortex. It is concluded that there seems to be no specific respiratory chain defect in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393094     DOI: 10.1007/bf00839971

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Mitochondrial DNA in postmortem brain from patients with Parkinson's disease.

Authors:  P Lestienne; I Nelson; P Riederer; H Reichmann; K Jellinger
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

2.  Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence.

Authors:  S Ikebe; M Tanaka; K Ohno; W Sato; K Hattori; T Kondo; Y Mizuno; T Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

3.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  Mitochondrial function in Parkinson's disease.

Authors:  L A Bindoff; M Birch-Machin; N E Cartlidge; W D Parker; D M Turnbull
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

5.  Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease.

Authors:  D C Wallace; X X Zheng; M T Lott; J M Shoffner; J A Hodge; R I Kelley; C M Epstein; L C Hopkins
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

6.  Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic electrical stimulation in rabbits.

Authors:  H Reichmann; H Hoppeler; O Mathieu-Costello; F von Bergen; D Pette
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

7.  A method for quantitative extraction of enzymes and metabolites from tissue samples in the milligram range.

Authors:  D Pette; H Reichmann
Journal:  J Histochem Cytochem       Date:  1982-04       Impact factor: 2.479

8.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

9.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

10.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

View more
  8 in total

Review 1.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

2.  Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients.

Authors:  P Bongioanni; M Donato; M Castagna; F Gemignani
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Polymorphic variation in cytochrome oxidase subunit genes.

Authors:  Jianghua Lu; Kaixuan Wang; Mariana Rodova; Raquel Esteves; Diana Berry; Lezi E; Adam Crafter; Matthew Barrett; Sandra M Cardoso; Isaac Onyango; W Davis Parker; Joseph Fontes; Jeffrey M Burns; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Brain mitochondrial dysfunction in ovariectomized mice injected with D-galactose.

Authors:  Yang Su; Hao Sun; Jie Fang; Gang Hu; Ming Xiao
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

5.  Inhibition of heme synthesis alters Amyloid Precursor Protein processing.

Authors:  Luisa Benerini Gatta; Massimiliano Vitali; Rosanna Verardi; Paolo Arosio; Dario Finazzi
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

Review 6.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

7.  Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Authors:  Alba Pesini; Eldris Iglesias; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Patricia Meade; Paula Gaudó; Irene Jiménez-Salvador; Pol Andrés-Benito; Julio Montoya; Isidro Ferrer; Pedro Pesini; Eduardo Ruiz-Pesini
Journal:  Aging (Albany NY)       Date:  2019-09-27       Impact factor: 5.682

Review 8.  Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

Authors:  Zhibin Liang; Antonio Currais; David Soriano-Castell; David Schubert; Pamela Maher
Journal:  Pharmacol Ther       Date:  2020-11-20       Impact factor: 12.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.